DE2808116A1 - Verfahren zur herstellung von aethern von clavulansaeureestern - Google Patents

Verfahren zur herstellung von aethern von clavulansaeureestern

Info

Publication number
DE2808116A1
DE2808116A1 DE19782808116 DE2808116A DE2808116A1 DE 2808116 A1 DE2808116 A1 DE 2808116A1 DE 19782808116 DE19782808116 DE 19782808116 DE 2808116 A DE2808116 A DE 2808116A DE 2808116 A1 DE2808116 A1 DE 2808116A1
Authority
DE
Germany
Prior art keywords
general formula
radical
halide
group
clavulanic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19782808116
Other languages
German (de)
English (en)
Inventor
Thomas Trefor Howarth
Kong Luk
Roger John Ponsford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB10082/77A external-priority patent/GB1582864A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of DE2808116A1 publication Critical patent/DE2808116A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19782808116 1977-03-10 1978-02-24 Verfahren zur herstellung von aethern von clavulansaeureestern Withdrawn DE2808116A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1011677 1977-03-10
GB10082/77A GB1582864A (en) 1977-03-10 1977-03-10 Chemical process for the preparation of clavulanic acid derivatives

Publications (1)

Publication Number Publication Date
DE2808116A1 true DE2808116A1 (de) 1978-09-21

Family

ID=26247246

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782808116 Withdrawn DE2808116A1 (de) 1977-03-10 1978-02-24 Verfahren zur herstellung von aethern von clavulansaeureestern

Country Status (19)

Country Link
JP (1) JPS53112894A (nl)
AR (1) AR216505A1 (nl)
AT (1) AT359188B (nl)
AU (1) AU519232B2 (nl)
CH (1) CH632760A5 (nl)
DE (1) DE2808116A1 (nl)
DK (1) DK139377A (nl)
ES (1) ES467513A1 (nl)
FI (1) FI65252C (nl)
FR (1) FR2383184A1 (nl)
GR (1) GR64160B (nl)
HK (1) HK15084A (nl)
IE (1) IE46478B1 (nl)
IL (1) IL54078A0 (nl)
KE (1) KE3337A (nl)
MX (1) MX4864E (nl)
NL (1) NL7802596A (nl)
NO (1) NO771106L (nl)
SE (1) SE442748B (nl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002370A1 (en) * 1977-12-02 1979-06-13 Beecham Group Plc A process for the preparation of ether derivatives of clavulanic acid
EP0301394A1 (de) * 1987-07-31 1989-02-01 Pfaendler, Hans Rudolf, Prof. Dr. Stabile Oxapenem- 3-carbonsäuren

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58187371A (ja) * 1982-04-27 1983-11-01 Nec Corp 印字濃度制御回路

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573503A (en) * 1975-12-17 1980-08-28 Glaxo Lab Ltd Clavulanic acid derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002370A1 (en) * 1977-12-02 1979-06-13 Beecham Group Plc A process for the preparation of ether derivatives of clavulanic acid
EP0301394A1 (de) * 1987-07-31 1989-02-01 Pfaendler, Hans Rudolf, Prof. Dr. Stabile Oxapenem- 3-carbonsäuren
US5096899A (en) * 1987-07-31 1992-03-17 Bayer Aktiengesellschaft Oxapenem-3-carboxylic acids

Also Published As

Publication number Publication date
FI65252B (fi) 1983-12-30
SE7704085L (sv) 1978-09-11
FI771146A (fi) 1978-09-11
ES467513A1 (es) 1979-08-01
AU519232B2 (en) 1981-11-19
HK15084A (en) 1984-02-24
MX4864E (es) 1982-11-10
FI65252C (fi) 1984-04-10
CH632760A5 (en) 1982-10-29
DK139377A (da) 1978-09-11
IE46478B1 (en) 1983-06-29
AR216505A1 (es) 1979-12-28
AU3384078A (en) 1979-09-06
SE442748B (sv) 1986-01-27
GR64160B (en) 1980-02-05
NO771106L (no) 1978-09-12
IE780477L (en) 1978-09-10
FR2383184B1 (nl) 1980-08-29
KE3337A (en) 1983-11-25
IL54078A0 (en) 1978-04-30
AT359188B (de) 1980-10-27
ATA145178A (de) 1980-03-15
JPS53112894A (en) 1978-10-02
FR2383184A1 (fr) 1978-10-06
NL7802596A (nl) 1978-09-12

Similar Documents

Publication Publication Date Title
DE2729859C2 (de) Verfahren zur Herstellung von 6a,10a-cis- oder -trans-1-Hydroxy-3-alkyl-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-onen
DE68918241T2 (de) Phosphonatreagenz-Zusammensetzungen und Verfahren zu ihrer Herstellung.
DE1443338C3 (de) Verfahren zur Herstellung von cyclischen 6-Ring-Äthern
DE19900172C2 (de) Verfahren zur Herstellung von L-p-Boronophenylalanin und Zwischenprodukt zur Herstellung desselben
DE2808116A1 (de) Verfahren zur herstellung von aethern von clavulansaeureestern
DE2029099C3 (de) Verfahren zur Herstellung von Acetidino [3,2-d] thiazolen
DE3127989C2 (de) 20-Isocyano-3-methoxy-pregna-3,5,17(20)-trien, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung von 17alpha-Hydroxy-progesteron
DE1470022A1 (de) Verfahren zur Herstellung chemischer Verbindungen
CH659464A5 (de) Verfahren zur herstellung von 1,8-dihydroxy-10-acyl-9-anthronen.
DE1668365A1 (de) Keten-trialkylsilyl-acetale und Verfahren zu ihrer Herstellung
DE1242216B (de) Verfahren zur Herstellung von Inaminsalzen
DE2516544A1 (de) Verfahren zur herstellung von trans-decalin-derivaten
DE869965C (de) Verfahren zur Zerlegung der diastereomeren Formen von dl-Aminodiolen
DE2415765A1 (de) 3-hydroxy-5-oxo-2-substituierte cyclopentanalkensaeuren
DE2350680C3 (de) Verfahren zur Herstellung von am Ring substituierten Derivaten der (-) -Podocarpensäure
DE1643008C3 (de) Verfahren zur Herstellung von 17Äthinyl-Delta hoch 16 -steroiden
DE915691C (de) Verfahren zur Herstellung von Dialkylmalonsaeureestern
AT350200B (de) Verfahren zur herstellung von neuen steroid- spirolactonen
AT236948B (de) Verfahren zur Herstellung von neuen 4-Methyl-5-kohlenwasserstoff-oxy-oxazolen
DE952715C (de) Verfahren zur Herstellung neuer antihistaminwirksamer basischer AEther
DE2409597C2 (de) Verfahren zur Herstellung von Bicycloalkan-Carbonsäuren
DE1130440B (de) Verfahren zur Herstellung von 2-Aminomethylderivaten von ?-3-Keto-steroiden
DE1044102B (de) Verfahren zur Herstellung von Estern der Xanthen-9-carbonsaeure
CH615923A5 (en) Process for the preparation of optically active oxetanes
DE1643008B2 (de) Verfahren zur Herstellung von 17Äthinyl-Delta hoch 16 -steroiden

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: JUNG, E., DIPL.-CHEM. DR.PHIL. SCHIRDEWAHN, J., DI

8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee